share_log

3SBio Secures Exclusive License to CStone's Anti-Tumor Drug in China

MT Newswires ·  11/02/2023 19:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment